Trials / Completed
CompletedNCT03260543
Efficacy and Safety of Fermented Ginseng Powder on Liver Function
A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Fermented Ginseng Powder on Liver Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the effects of daily supplementation of fermented ginseng powder on improvement of Liver function.
Detailed description
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of fermented ginseng powder on improvement of Liver function. The investigators measured ALT(Alanine Transaminase) profiles, Liver function index, fatty liver grade, lipid metabolism index, total antioxidant capacity, imflammation index, and Multidimensional Fatigue Scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | fermented ginseng powder | tablets (2 tablets/day, 125 mg \& 500 mg/day) for 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo for 12 weeks. |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-11-01
- Completion
- 2017-08-01
- First posted
- 2017-08-24
- Last updated
- 2018-02-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03260543. Inclusion in this directory is not an endorsement.